Table 1 Association between the expression level of miR-133a-3p or GAPARAPL1 and the clinical characteristics in GC patients
| Parameters | Group | miR-133a-3p expression | GABARAPL1 expression | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Cases | Low | High | P-value | Cases | Low | High | P-value | ||
| Gender |
female male |
24 56 |
13 27 |
11 29 | 0.6256 |
15 35 |
7 18 |
8 17 | 0.7576 |
| Age at surgery |
≥ 55 < 55 |
64 16 |
29 11 |
35 5 | 0.0935 |
7 43 |
5 20 |
2 23 | 0.2214 |
| T grade |
T1 + T2 T3 + T4 |
45 35 |
21 19 |
24 16 | 0.4990 |
24 26 |
14 11 |
10 15 | 0.2575 |
| Lymphatic invasion |
Negative(N0) Positiv(N1-N3) |
23 57 |
7 33 |
16 24 | 0.0262* |
20 30 |
12 13 |
8 17 | 0.2482 |
| Tumor site |
Cardiac Non-cardiac |
30 50 |
16 24 |
14 26 | 0.6442 |
18 32 |
12 13 |
6 19 | 0.0771 |
| Stage |
I-II III-IV |
41 39 |
18 22 |
23 17 | 0.2634 |
23 27 |
14 11 |
9 16 | 0.1560 |
| Size(cm) |
< 3 ≥ 3 |
37 43 |
13 27 |
24 162 | 0.0136* |
21 29 |
14 11 |
7 18 | 0.0449* |
| Histology grade |
Well-moderately Poorly-signet |
25 55 |
15 25 |
10 30 | 0.2278 0. |
17 33 |
10 15 |
7 18 | 0.3705 |